logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
T

Therapeutic Advances in Psychopharmacology

IF4
Papers452
Citations1541
Journal Papers 451
Publication Date
delete
The pharmacotherapeutic use of clozapine in older adults: A narrative review
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-09-29
delete0
PREAI
deleteKate Mulholland; Brian O’ Donoghue; Dan Siskind; Geraldine McCarthy; John Lally
deleteShare
deleteSave
A systematic review of case reports and case series of zolpidem in the diagnosis and treatment of catatonia
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-09-25
delete0
PREAI
deleteNiraj Ahuja; Harry Hackett; Joseph Thorne; Stuart Watson; Richard Hamish McAllister-Williams
deleteShare
deleteSave
Incidence of antidepressant withdrawal reactions: A prospective longitudinal cohort study in primary care patients
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-09-24
delete0
PREAI
deleteAndri Rennwald; Mark A. Horowitz; Oliver Senn; Stefan Neuner-Jehle; Michael P. Hengartner
deleteShare
deleteSave
Repurposing incretin-based therapies for alcohol use disorder: a systematic review of efficacy and safety relative to standard pharmacotherapies in a recent comparative context
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-09-22
delete0
PREAI
deleteAristomenis G. Alevizopoulos; Vasileios Vasilakos; Iakovos Kritikos; Maria Alevizopoulou; Eleni Korompoki; Theodora Psaltopoulou; Stavroula A. Paschou
deleteShare
deleteSave
Expert opinion survey on the pharmacological treatment of insomnia in Japan (2025)
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-09-21
delete0
PREAI
deleteHiromi Tagata; Saki Hattori; Hitoshi Sakurai; Hideaki Tani; Yasushi Kawamata; Asuka Katsuki; Hiroyuki Muraoka; Shinichiro Ochi; Kyosuke Sawada; Akira Nishi; Toshiaki Kikuchi; Yoshiteru Takekita; Hajime Baba; Masaki Kato; Koichiro Watanabe; Ken Inada; Norio Yasui-Furukori; Junichi Iga
deleteShare
deleteSave
Efficacy and safety of ecopipam for Tourette syndrome: An updated systematic review and meta-analysis of randomized controlled trials
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-09-02
delete0
PREAI
deleteAasim Ali; Abdullah Shahid; Muhammad Usman; Asad Ullah Ansari; Labeeba Abdul Ghafoor; Csilla Dézsi; Viktor Gulyás-Oldal; Károly Szili; Muhammad Abdullah Ali; Usama Saleem; Muhammad Asad Shabbir; Armaghana Abdullah; Mukesh Kumar Sharma; Muhammad Talha
deleteShare
deleteSave
Real-world clinical practice, effectiveness and safety of esketamine nasal spray in major depressive disorder patients: a French prospective cohort (ELLIPSE study)
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-08-31
delete0
PREAI
deletePierre-Michel Llorca; Anne Sauvaget; Emilie Olié; Lila Mékaoui; Ludovic Samalin; Maud Rothärmel; Anne-Laure Boitez; Julien Dupin; Clotilde Wicart; Emeline Gaudre-Wattinne; Hugo Lacour; Benjamin Grenier; Bernard Astruc; Bruno Falissard; Pierre de Maricourt
deleteShare
deleteSave
Consent beyond the written form: Implications for ketamine trials in the Philippines
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-08-31
delete0
PREAI
deleteAbegail A. Pagallaman; John Noel E. Fermin
deleteShare
deleteSave
Informing the patient of the placebo option: an ethical necessity likely to reduce inappropriate psychotropic prescriptions?
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-08-31
delete0
PREAI
deleteFabrice Berna; Guillaume Durand; Rémy Boussageon; Julien Nizard; François Paille; Laurence Verneuil
deleteShare
deleteSave
Clinical response to clozapine in Black people with psychosis: A secondary analysis of an open-label clinical trial
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-08-22
delete0
PREAI
deleteAllison S. Brandt; Gopal Vyas; Taiwo Oduguwa; Adeola O. Adebayo; Heather A. Adams; Raymond C. Love; Russell L. Margolis; Robert W. Buchanan; Richard Adebayo; Deanna L. Kelly
deleteShare
deleteSave
Anticholinergic burden and its predictors among patients with schizophrenia in Northwest Ethiopia: An institutional-based cross sectional study
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-08-21
delete0
PREAI
deleteFasil Bayafers Tamene; Getachew Yitayew Tarekegn; Tilaye Arega Moges; Samuel Berihun Dagnew; Tigabu Eskeziya Zerihun; Abel Temeche Kassaw; Desalegn Addis Mussie; Woretaw Sisay Zewdu; Samuel Agegnew Wondm
deleteShare
deleteSave
The mechanism of action and clinical efficacy of xanomeline-trospium in schizophrenia: A comprehensive review
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-08-18
delete0
PREAI
deleteFeng Ji; Lijuan Ma; Xuning Shen; Xiaoling Liang; Wei Cui; Yucong Zhou; Xi-en Wang; Hao Liu
deleteShare
deleteSave
Efficacy and safety of semaglutide versus placebo for people with schizophrenia spectrum disorders with obesity or early-stage metabolic abnormalities: A systematic review and meta-analysis of randomized controlled studies
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-08-17
delete0
PREAI
deleteMinahil Rasul; Ahmad Hassan; Ubaid Ur Rehman; Muhammad Sarmad; Abdullah Shahid Farooq; Huzaifa Khalil; Muhammad Asad Jahangir; Zain Ul Abideen; Muhammad Kashif Bashir; Umaima Cheema; Maaz Amir; Mohammad Azeem Malik; Abdul Haseeb Hasan; Ramisha Tahir
deleteShare
deleteSave
Therapeutic apartheid: a cross-sectional assessment of estimated cost, accessibility, affordability, and availability among psychotropic medications across 25 regions
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-08-16
delete0
deleteOAAI
deleteJavier A. Flores-Cohaila; Luis Arturo Vílchez Salcedo; Carlos Alexis Salgado Valenzuela; Cesar Li Amenero; Jose Carlos Bojórquez-De la Torre; Ana Maria Zamalloa-Torres; Brayan Miranda-Chavez; Jeff Huarcaya-Victoria; Cesar Copaja-Corzo
deleteShare
deleteSave
Psychoactive drug use and substance-induced psychosis: Emerging challenges in a low-middle-income country
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-08-16
delete0
PREAI
deleteNabin Pathak; Sunil Shrestha
deleteShare
deleteSave
Same sample, different result: Variation in clozapine assay measurement in four UK laboratories
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-08-16
delete0
PREAI
deleteMatthew Atkins; James Fritz; Mary Rose Hilaire; David Taylor
deleteShare
deleteSave
Lithium-induced blepharospasm in a middle-aged woman with recurrent depressive disorder: a case report
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-08-05
delete0
PREAI
deleteMaria del Rosario Arevalo Bazalar; Jayamal De Silva
deleteShare
deleteSave
Seizures associated with clozapine augmentation by other antipsychotics: a pharmacovigilance–pharmacodynamic analysis using VigiBase
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-07-30
delete0
PREAI
deleteMasakazu Hatano; Hirofumi Hamano; Masaya Kanda; Takenao Koseki; Tsuyoshi Nakai; Rina Horii; Nozomi Yoshihara; Takeo Saito; Kenshi Takechi; Satoru Esumi; Yoshito Zamami; Shigeki Yamada
deleteShare
deleteSave
Oestrogen modulators as augmentation to antipsychotics for the treatment of post- and perimenopausal psychosis: a systematic review
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-07-29
delete0
PREAI
deleteCassidy Keen; Athanasios Hassoulas; Jill Richardson
deleteShare
deleteSave
Conceptual analysis of mechanisms and methods in psychedelic clinical trial design: a narrative review
deleteTherapeutic Advances in Psychopharmacology
IF4
delete2026-07-25
delete0
PREAI
deleteMartin Krsak; David Sparrow; Bernard Rosner; Deborah DeMolles; Scott Shannon
deleteShare
deleteSave